Stryker Corporation (Stryker) is a medical technology company. The Company provides orthopaedic implants, as well as medical and surgical equipment. It has two segments: Orthopaedic Implants and MedSurg Equipment. Its products include implants used in joint replacement, trauma and spinal surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. During the year ended December 31, 2010, it acquired Sonopet Ultrasonic Aspirator assets from Mutoh Co., Ltd. and Synergetics USA, Inc., Gaymar Industries, Inc. and the bioimplantable implants product line and related assets from Porex Surgical, Inc. In October 2010, it acquired Neurovascular division of Boston Scientific Corporation. In December 2010, it sold its OP-1 product family (More on Reuters).
Here are some Fundamental Figures:
Sales | 7.54 Bil |
Income | 1.26 Bil |
Net Profit Margin | 16.71% |
Return on Equity | 17.83% |
Debt/Equity Ratio | 0.14 |
Revenue/Share | 18.97 |
Earnings/Share | 3.17 |
Book Value/Share | 19.21 |
Dividend Rate | 0.72 |
Payout Ratio | 21.00% |
Here are some Pricing Figures:
Price/Earnings | 18.6 |
Price/Book | 3.1 |
Price/Sales | 3.1 |
Price/Cash Flow | 15.8 |
Dividend Yield % | 1.23 |
Forward Price/Earnings | 14.1 |
PEG Ratio | 1.2 |
PEG Payback (Yrs) | 7.7 |
Here are some Trading Figures:
Last Price | 58.67 |
52-Wk High | 65.21 |
52-Wk Low | 42.74 |
Volume | NA |
Avg Daily Vol (13 Wks) | 2.16 Mil |
50-Day Moving Average | 60.12 |
200-Day Moving Average | 56.6 |
Volatility (beta) | 0.92 |
Sales and Income of Stryker (Click to enlarge) |
Do you have further dividend ideas you want to share with our audience? Please contact us and submit your stock idea here: dividendyields@googlemail.com